Attenuation of Allergic Airway Inflammation and Hyper-responsiveness in a Murine Model of Asthma by Silver Nanoparticles
This is a groundbreaking clinical study concluding that silver nanoparticles might be effective in the prevention or treatment of asthma. According to the study authors, “Our study suggests that oxidative stress is an important determinant of allergic airway disease and that silver NPs attenuated oxidative stress in the murine asthma model.
Also, by administration of silver NPs, Th2 inflammation, which is one of the main asthma-inducing immune factors, was significantly decreased. We suggest that silver NPs may be useful as a therapeutic strategy through their properties as antioxidant and anti-inflammatory agents.”
